Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Novel Triple-dose Tuberculosis Retreatment Regimen — Stella

Home/Multidrug-resistant Tuberculosis/Novel Triple-dose Tuberculosis Retreatment Regimen

View on ClinicalTrials.gov

Recruiting

Back to Multidrug-resistant Tuberculosis trials

Novel Triple-dose Tuberculosis Retreatment Regimen

Phase 3 — Large-scale testing across thousands of people, comparing the new treatment against current standard treatments.

Trial locations(1 site)

Niger

Damien Foundation, Niamey

Key details

Phase

Large-scale testing

Sponsor

Institute of Tropical Medicine, Belgium

Collaborators

Damien Foundation

Enrollment target

~370 participants

Started

March 2021

Primary completion

June 2025

This trial's estimated completion date has passed — the record may not be fully up to date.

Last updated April 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.